Experimental Quad Regimen For HIV-1 Naïve Patients Meets Primary Endpoint In Trial
Links shared publicly online about this topic.
- 70total visits
Experimental Quad Regimen For HIV-1 Naïve Patients Meets Primary Endpoint In Trial
A Phase III clinical trial of Quad regimen including elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate for treatment naïve HIV-1 patients met its primary endpoint
View full resource at medicalnewstoday.com
Tags: Hepatitis B Medication, HIV Medication, Clinical Trial, Viread, Emtriva
Most Recently Shared on August 15, 2011 at 8:05 pm By:
Experimental Quad Regimen For HIV-1 Naïve Patients Meets Primary Endpoint In Trial http://mnt.to/3YXb #hivaids
Also Shared By:
Advertisement
MNT Health News
@mnt_healthnews
Experimental Quad Regimen For HIV-1 Naïve Patients Meets Primary Endpoint In Trial http://mnt.to/3YXb #healthnews
1 year ago...